Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19

NCT04567173 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped Limited enrolment (unable to achieve target sample size)

Conditions

Covid19

Interventions

DRUG: Anti-SARS-CoV-2 convalescent plasma

Sponsor

University of the Philippines